Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 2: Currently Available Oral Therapies for Moderate-to-Severe Atopic Dermatiti

Target Audience
This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis.

Program Overview
This activity features a case presentation, a brief overview of currently available oral therapies, and insights from expert faculty.

Learning Objectives
After completing this activity, the participant should be better able to::

Identify the biologic properties and mechanisms of action of current and emerging biological therapies for moderate-to-severe atopic dermatitis
Evaluate evidence on the efficacy and safety, along with the impact on patients’ quality of life, of current and emerging biological therapies for moderate-to-severe atopic dermatitis
Apply patient-, disease-, and therapy-specific considerations in treatment decisions for patients with moderate-to-severe atopic dermatitis